30 April 2020

Safety alerts and Withdrawal for Medical & Pharmaceutical Products not register in the Drug Control in MOHAP

Reference: CIR-2019-00000056

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Safety alerts for the medical device Swan-Ganz Thermodilution Catheter
• Withdrawal five batch’s from the Pharmaceutical Product (Amubaro)

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

سحب خمسة تشغيلات من المستحضر الطبي ( Amubaro ) المحتوية على المادة الفعالةValsartan.docx:

View Document

Circular # 19-Safety alerts for the medical device Swan-Ganz Thermodilution Catheter.doc:

View Document